Actively Recruiting
INNODIA Early Detection Study for Family and Friends at Risk of Type 1 Diabetes
Led by INNODIA iVZW · Updated on 2026-08-24
30000
Participants Needed
21
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating how to identify individuals at increased risk of developing Type 1 Diabetes T1D, a serious condition where the body cannot produce insulin, leading to high blood sugar levels. The study focuses on detecting specific markers in the blood called autoantibodies, which signal the early onset of T1D before symptoms appear. The risk of developing T1D grows with the number of these autoantibodies found, especially in people with a family member or close friend who has been diagnosed with T1D before age 45. Participants, aged 1 to 45 years, who have a relative or close friend diagnosed with T1D will provide a small blood sample to test for the presence of T1D autoantibodies. If no autoantibodies are detected, the participant is considered at low risk and will exit the study. If one or more autoantibodies are found, participants will be invited for a confirmation blood test conducted as part of their routine clinical care. Following confirmation, participants may be invited to join a separate follow-up study. During the study, participants provide blood samples for testing. The main outcome measured is the presence of one or more T1D autoantibodies by the end of 2027. Participants with negative results will have no further visits, while those with positive results will continue with confirmation testing and may join additional monitoring protocols. The study is observational and involves minimal participant burden, with the overall duration extending until December 2027.
CONDITIONS
Brief Title
INNODIA Family & Friends Early-Stage T1D Detection Protocol
Research Team
L
Laura Moreno Belmonte
P
Program Manager
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here